0001209191-22-028719.txt : 20220512
0001209191-22-028719.hdr.sgml : 20220512
20220512211457
ACCESSION NUMBER: 0001209191-22-028719
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220510
FILED AS OF DATE: 20220512
DATE AS OF CHANGE: 20220512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clements Ian
CENTRAL INDEX KEY: 0001780080
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38981
FILM NUMBER: 22919893
MAIL ADDRESS:
STREET 1: C/O MIRUM PHARMACEUTICALS, INC.
STREET 2: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001759425
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831281555
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-667-4085
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-10
0
0001759425
Mirum Pharmaceuticals, Inc.
MIRM
0001780080
Clements Ian
C/O MIRUM PHARMACEUTICALS, INC.
950 TOWER LANE, SUITE 1050
FOSTER CITY
CA
94404
0
1
0
0
Chief Financial Officer
Common Stock
2022-05-10
5
A
0
E
1125
13.566
A
29686
D
This Form 4 is being filed voluntarily to report the acquisition of 1,125 shares by the Reporting Person on May 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
/s/ Jody Howe, Attorney-in-Fact
2022-05-12